Peer-reviewed veterinary case report
Plant-based dog food lowers heart risk chemicals in healthy dogs
By Cavanaugh, Sarah M et al.·Published in Frontiers in veterinary science·2022·Department of Clinical Sciences·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Commercial Extruded Plant-Based Diet Lowers Circulating Levels of Trimethylamine-Oxide (TMAO) Precursors in Healthy Dogs: A Pilot Study.
- Species:
- dog
Plain-English summary
A group of healthy mixed-breed dogs was fed either a plant-based diet or a traditional diet containing animal ingredients to see how it affected certain substances in their blood related to heart health. After four weeks, the dogs on the plant-based diet had lower levels of two precursors (choline and betaine) linked to trimethylamine-oxide (TMAO), which is associated with heart problems. However, the overall TMAO levels did not change significantly between the two diets. This suggests that while a plant-based diet can lower some harmful precursors, it may not impact TMAO levels in healthy dogs.
People also search for: dog heart health diet · plant-based diet for dogs · TMAO levels in dogs
Abstract
Elevations in circulating trimethylamine-oxide (TMAO) and its precursors are observed in humans and dogs with heart failure and are associated with adverse outcomes in people. Dietary intervention that reduces or excludes animal ingredients results in rapid reduction of plasma TMAO and TMAO precursors in people, but the impact of diet in dogs has not been studied. The objective of the current study was to determine the effect of diet on plasma TMAO and 2 of its precursors (choline and betaine) in dogs fed a commercial extruded plant-based diet (PBD) or a commercial extruded traditional diet (TD) containing animal and plant ingredients. Sixteen healthy adult mixed breed dogs from a university colony were enrolled in a randomized, 2-treatment, 2-period crossover weight-maintenance study. Mean (SD) age and body weight of the dogs were 2.9 years (± 1.7) and 14.5 kg (± 4.0),. Eight dogs were female (3 intact, 5 spayed) and 8 dogs were male (4 intact, 4 castrated). Plasma choline, betaine and TMAO were quantified by LC-SID-MRM/MS at baseline, and after 4 weeks on each diet. Choline and betaine were also quantified in the diets. Plasma choline levels were significantly lower (= 0.002) in dogs consuming a PBD (Mean ± SD, 6.8 μM ± 1.2 μM) compared to a TD (Mean ± SD, 7.8 μM ± 1.6 μM). Plasma betaine levels were also significantly lower (= 0.03) in dogs consuming a PBD (Mean ± SD, 109.1 μM ± 25.3 μM) compared to a TD (Mean ± SD, 132.4 μM ± 32.5 μM). No difference (= 0.71) in plasma TMAO was detected in dogs consuming a PBD (Median, IQR, 2.4 μM, 2.1 μM) compared to a TD (Median, IQR, 2.3 μM, 1.1 μM). Betaine content was lower in the PBD than in the TD while choline content was similar in the diets. Our findings indicate consumption of a commercial extruded PBD for 4 weeks reduces circulating levels of the TMAO precursors choline and betaine, but not TMAO, in healthy adult dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/35873695/